Literature DB >> 16282487

Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription.

Peggy Möller1, Nonia Pariente, Hans-Dieter Klenk, Stephan Becker.   

Abstract

The nucleocapsid protein VP35 of Marburgvirus, a filovirus, acts as the cofactor of the viral polymerase and plays an essential role in transcription and replication of the viral RNA. VP35 forms complexes with the genome encapsidating protein NP and with the RNA-dependent RNA polymerase L. In addition, a trimeric complex had been detected in which VP35 bridges L and the nucleoprotein NP. It has been presumed that the trimeric complex represents the active polymerase bound to the nucleocapsid. Here we present evidence that a predicted coiled-coil domain between amino acids 70 and 120 of VP35 is essential and sufficient to mediate homo-oligomerization of the protein. Substitution of leucine residues 90 and 104 abolished (i) the probability to form coiled coils, (ii) homo-oligomerization, and (iii) the function of VP35 in viral RNA synthesis. Further, it was found that homo-oligomerization-negative mutants of VP35 could not bind to L. Thus, it is presumed that homo-oligomerization-negative mutants of VP35 are unable to recruit the polymerase to the NP/RNA template. In contrast, inability to homo-oligomerize did not abolish the recruitment of VP35 into inclusion bodies, which contain nucleocapsid-like structures formed by NP. Finally, transcriptionally inactive mutants of VP35 containing the functional homo-oligomerization domain displayed a dominant-negative phenotype. Inhibition of VP35 oligomerization might therefore represent a suitable target for antiviral intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282487      PMCID: PMC1287548          DOI: 10.1128/JVI.79.23.14876-14886.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  A simple and rapid method for generating a deletion by PCR.

Authors:  Y Imai; Y Matsushima; T Sugimura; M Terada
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

Review 2.  Co- and posttranslational modifications and functions of Marburg virus proteins.

Authors:  S Becker; E Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

3.  Alpha-helical coiled coils: more facts and better predictions.

Authors:  C Cohen; D A Parry
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

4.  An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication.

Authors:  J Curran; J B Marq; D Kolakofsky
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

5.  Crystal structure of an isoleucine-zipper trimer.

Authors:  P B Harbury; P S Kim; T Alber
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

6.  Domains of Rinderpest virus phosphoprotein involved in interaction with itself and the nucleocapsid protein.

Authors:  D Shaji; M S Shaila
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

7.  Measles virus phosphoprotein (P) requires the NH2- and COOH-terminal domains for interactions with the nucleoprotein (N) but only the COOH terminus for interactions with itself.

Authors:  R N Harty; P Palese
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

8.  Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.

Authors:  E Mühlberger; M Weik; V E Volchkov; H D Klenk; S Becker
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Paramyxovirus phosphoproteins form homotrimers as determined by an epitope dilution assay, via predicted coiled coils.

Authors:  J Curran; R Boeck; N Lin-Marq; A Lupas; D Kolakofsky
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

10.  Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses.

Authors:  A Sanchez; M P Kiley; H D Klenk; H Feldmann
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

View more
  31 in total

1.  Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread.

Authors:  Kristina Maria Schmidt; Michael Schümann; Judith Olejnik; Verena Krähling; Elke Mühlberger
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.

Authors:  Kathleen C Prins; Jennifer M Binning; Reed S Shabman; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Mapping and functional role of the self-association domain of vesicular stomatitis virus phosphoprotein.

Authors:  Mingzhou Chen; Tomoaki Ogino; Amiya K Banerjee
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Vacuolar protein sorting pathway contributes to the release of Marburg virus.

Authors:  Larissa Kolesnikova; Thomas Strecker; Eiji Morita; Florian Zielecki; Eva Mittler; Colin Crump; Stephan Becker
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

5.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Authors:  A Groseth; J E Charton; M Sauerborn; F Feldmann; S M Jones; T Hoenen; H Feldmann
Journal:  Virus Res       Date:  2008-12-16       Impact factor: 3.303

6.  Expression, purification, crystallization and preliminary X-ray studies of the Ebola VP35 interferon inhibitory domain.

Authors:  Daisy W Leung; Nathaniel D Ginder; Jay C Nix; Christopher F Basler; Richard B Honzatko; Gaya K Amarasinghe
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

7.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

8.  RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Authors:  Nadine Biedenkopf; Julia Schlereth; Arnold Grünweller; Stephan Becker; Roland K Hartmann
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

9.  Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.

Authors:  Baocheng Liu; Shishang Dong; Guobang Li; Wenming Wang; Xiang Liu; Yantong Wang; Cheng Yang; Zihe Rao; Yu Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

10.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.